C1 Esterase Inhibitor. PMID: 30000948
Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment. PMID: 27018196
Acquired C1 Inhibitor Deficiency. PMID: 28687105
C1-based biomanufacturing: Advances, challenges and perspectives. PMID: 36347475
Interaction between C1-microorganisms and plants: contribution to the global carbon cycle and microbial survival strategies in the phyllosphere. PMID: 36367545
C1-inhibitor deficiency and angioedema. PMID: 11532278
C1-inhibitor: more than a serine protease inhibitor. PMID: 21805442
Activation of C1. PMID: 6149573
C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. PMID: 19162547
C1 inhibitor deficiency: diagnosis. PMID: 15953110
Anti-C1-Inhibitor Autoantibody Detection by ELISA. PMID: 33847936
[C1 inhibitor deficiency]. PMID: 11212696
The C1 inhibitor deficiency. A review. PMID: 1489854
C1 inhibitor: molecular and clinical aspects. PMID: 16267649
Mechanisms of C1-inhibitor deficiency. PMID: 12396014
C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema. PMID: 10699156
The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema. PMID: 20455857
The thrombogenicity of C1 esterase inhibitor (human): review of the evidence. PMID: 25584911
Hereditary angioedema with normal C1-INH (HAE type III). PMID: 24565612
C1 inhibitor. PMID: 8271970
Angio-oedema due to hereditary C1 inhibitor deficiency in children. PMID: 22417938
C1 inhibitor and hereditary angioneurotic edema. PMID: 3289579
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity. PMID: 26068904
Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema. PMID: 29909591
Cytochrome c1 complexes. PMID: 33986
Current treatment options for hereditary angioedema due to C1 inhibitor deficiency. PMID: 26512744
Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema. PMID: 21942916
Structure and function of C1-inhibitor. PMID: 17085281
Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management. PMID: 23678554
Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. PMID: 24635050
The safety of treatments for angioedema with hereditary C1 inhibitor deficiency. PMID: 26429506
The C1 esterase inhibitor and hereditary angioedema. PMID: 7040439
C1 Inhibitor Activity and Angioedema Attacks in Patients with Hereditary Angioedema. PMID: 31655295
Recombinant human C1 esterase inhibitor (Conestat alfa) for prophylaxis to prevent attacks in adult and adolescent patients with hereditary angioedema. PMID: 30021471
Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency. PMID: 26250409
Influence of C1-inhibitor on inflammation, edema and shock. PMID: 8172580
C1-inhibitor/C1-inhibitor antibody complexes in acquired angioedema due to C1-inhibitor deficiency. PMID: 36726161
Acquired C1-inhibitor deficiency. PMID: 2679531
Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: a systematic literature review. PMID: 23710659
C1-inhibitor and its genetic alterations in hereditary angioneurotic edema. PMID: 8340674
[C1-inhibitor (C1-INH)]. PMID: 8753458
Structural and functional aspects of C1-inhibitor. PMID: 12396012
The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema. PMID: 18035961
The first component of human complement (C1): activation and control. PMID: 6314572
C1-inhibitor--biochemical properties and clinical applications. PMID: 3899511
Recombinant human C1 esterase inhibitor for the treatment of hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE). PMID: 25669442
Efficient C1 Elongation by Reversing α-Oxidation. PMID: 31668766
Inherited C1 inhibitor deficiency. PMID: 2656079
C1 subcomponent complexes: basic and clinical aspects. PMID: 8172579
Combined C1-2 transarticular screw fixation and C1 laminoplasty with interlaminar bone transplant for retro-odontoid pseudotumor: illustrative case. PMID: 36303498
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic. PMID: 23137231
C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. PMID: 18613773
Posterior temporary fixation of C1-C2 screw-rod system for unstable C1 burst fracture. PMID: 35945753
An alternative way of C1 screwing: Supralaminar C1 lateral mass screws. PMID: 34194167
Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency. PMID: 22014012
Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients. PMID: 32431708
Reference range for C1-esterase inhibitor (C1 INH) in the third trimester of pregnancy. PMID: 32887189
[C1 inhibitor deficiency. Heredity and acquired forms. Symptoms, diagnostic and therapeutic problems]. PMID: 12418282
Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency. PMID: 24490128
C1-inhibitor: structure/function and biologic role. PMID: 8172569
Aspects of C1-inhibitor biochemistry and pathophysiology. PMID: 3327641
C1 inhibitor: quantification and purification. PMID: 24218261
Human astrovirus coat protein: a novel C1 inhibitor. PMID: 19025126
C1- inhibitors and their genes: an update. PMID: 1583381
Structure and function of C1 inhibitor. PMID: 2679529
The acquired C1-INH deficiencies with autoantibodies (AAE type II). PMID: 2679532
C1 esterase inhibitor use in the management of lisinopril-induced angioedema: A case series. PMID: 32727672
Radiographic and Clinical Results of C1 Laminoplasty for the Treatment of Compressive Myelopathy. PMID: 31992026
[Hereditary or acquired angioedema caused by functional deficiency of C1 inhibitor--a still unfamiliar disease picture]. PMID: 10093876
C1 inhibitor in sepsis and clinical outcome. PMID: 27106052
Surgical treatment of chronic C1-C2 dislocation with absence of odontoid process using C1 hooks with C2 pedicle screws: a case report and review of literature. PMID: 21358484
The biological role of the C1 inhibitor in regulation of vascular permeability and modulation of inflammation. PMID: 14975261
C1, the first component of complement: structure-function-relationship of C1q and collectins (MBP, SP-A, SP-D, conglutinin), C1-esterases (C1r and C1s), and C1-inhibitor in health and disease. PMID: 8172555
C1 inhibitor deficiency: molecular and immunologic basis of hereditary and acquired angioedema. PMID: 1921329
Three-dimensional structure and molecular modelling of C1- inhibitor. PMID: 8172587
Preparation and properties of human C1 inhibitor. PMID: 6281621
C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk. PMID: 25103795
Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence? PMID: 15857357
Quantification of human C1 esterase inhibitor protein using an automated turbidimetric immunoassay. PMID: 30058083
Hereditary and acquired deficiencies of C1 inhibitor. PMID: 2698641
Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment. PMID: 26795750
Models for C1. Tools or toys? The real biological challenge. PMID: 2552979
Cut-off value of C1-inhibitor function for the diagnosis of hereditary angioedema due to C1-inhibitor deficiency. PMID: 33614375
Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate. PMID: 30866985
C1 inhibitor. Functional analysis of naturally-occurring mutant proteins. PMID: 9433501
C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema. PMID: 25800206
C1-inhibitor in hereditary angioneurotic edema: types I and II. PMID: 2679530
C1 activation and dissociation in disease. PMID: 3032782
Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response., PMID:15188075
[Significance of polypeptide antigen of HCVE2/NS1 relative conservation region in detection of anti-HCV]., PMID:12759957
Expression and purification of E2/NS1 protein of hepatitis C virus and detection of anti-E2/NS1 antibodies in chronic liver disease patients., PMID:12595764
Identification of human hepatocyte protein(s), which binds specifically to the recombinant envelope-2/non-structural-1 protein of hepatitis C virus., PMID:12191777
Antibody response to E2 glycoprotein induced in mice by immunization with plasmid DNA containing sequence derived from a Chinese genotype III/2a isolate of hepatitis C virus., PMID:11593587
Molecular design and immunogenicity studies of multiple antigenic peptide corresponding to envelope glycoprotein hypervariable region 1 of hepatitis C virus., PMID:11503045
Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C., PMID:11394572
[Expression of glycoprotein hepatitis C virus in mammalian cell and application of purified protein for detection of antibody against E2 in hepatitis C patients]., PMID:10715790
Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C., PMID:9076628
Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients., PMID:8959633
Lack of correlation between different hepatitis C virus screening and confirmatory assays., PMID:8793841
Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection., PMID:8621173
Fraction-specific populations of the hypervariable region of the hepatitis C virus in a patient with cryoglobulinemia., PMID:7595420
Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses., PMID:7815542
The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1., PMID:7503672
Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees., PMID:7941335
[Evolution of hepatitis C virus (HCV) viremia and adaptation of HCV in persistent infection in patients with acute hepatitis]., PMID:7521430
Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells., PMID:8212557
Hypervariable 5'-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants., PMID:7689636
[Hepatitis C]., PMID:8345654
Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein., PMID:7680297
[Expression of hepatitis C virus genome]., PMID:7681882
Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease., PMID:7686121
Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease., PMID:1314578
For research use only. Not for human or drug use.
